Home/Filings/4/0001062993-25-001660
4//SEC Filing

McManus Matthew 4

Accession 0001062993-25-001660

CIK 0000842023other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:31 PM ET

Size

16.4 KB

Accession

0001062993-25-001660

Insider Transaction Report

Form 4
Period: 2025-02-01
McManus Matthew
President - DGS
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-01+4,6204,620 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-014,6209,241 total
    Common Stock (4,620 underlying)
  • Tax Payment

    Common Stock

    2025-02-01$73.55/sh1,642$120,7692,978 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $68.54Exp: 2031-02-01Common Stock (15,902 underlying)
    15,902
  • Performance Restricted Stock Units

    Common Stock (15,825 underlying)
    15,825
  • Stock Option (Right to Buy)

    Exercise: $74.91Exp: 2034-08-15Common Stock (21,320 underlying)
    21,320
  • Performance Restricted Stock Units

    Common Stock (2,888 underlying)
    2,888
  • Performance Stock Option (Right to Buy)

    Exercise: $68.54Exp: 2031-02-01Common Stock (7,951 underlying)
    7,951
  • Restricted Stock Units

    Common Stock (7,912 underlying)
    7,912
Footnotes (7)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F3]4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
  • [F4]Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
  • [F5]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.
  • [F7]Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001908268

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:31 PM ET
Size
16.4 KB